Alpha Tau Medical (DRTS) Assets (2020 - 2026)

Alpha Tau Medical (DRTS) has 7 years of Assets data on file, last reported at $108.8 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 34.41% year-over-year to $108.8 million; the trailing twelve-month figure through Mar 2026 stood at $108.8 million (up 34.41% YoY), and the FY2025 full-year result was $105.7 million, up 22.56% from the prior year.
• Assets grew to $108.8 million in Q1 2026, from $105.7 million in the prior quarter.
• In the past five years, Assets ranged from a high of $124.0 million in Q2 2022 to a low of $80.9 million in Q1 2025.
• A 5-year average of $106.5 million and a median of $107.4 million in 2023 frame the typical range for Assets.
• Across the five-year window, Assets soared 184.61% in 2022 and declined 21.0% in 2025, its largest moves.
• Tracing DRTS's Assets over 5 years: stood at $120.1 million in 2022, then declined by 10.62% to $107.4 million in 2023, then declined by 19.73% to $86.2 million in 2024, then increased by 22.56% to $105.7 million in 2025, then grew by 2.95% to $108.8 million in 2026.
• Business Quant data shows DRTS's Assets at $108.8 million in Q1 2026, $105.7 million in Q4 2025, and $104.7 million in Q3 2025.